Skip to main content
. Author manuscript; available in PMC: 2021 Jun 21.
Published in final edited form as: Cell Physiol Biochem. 2017 Feb 3;41(2):555–568. doi: 10.1159/000457877

Fig. 6.

Fig. 6.

CD38 gene deficiency or chlo treatment prevents ubiquitinylation and degradation of CDK1 in coronary arteries of mice. (A and C) Representative western blot gel documents, (B and D) summarized densitometric data showing protein abundance of CDK1 or free ubiquitin in coronary arteries of CD38+/+ or CD38−/− mice under ctrl or chlo treatment. n=4, *P<0.05 vs. CD38+/+ ctrl.